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Publ isher's Announcement  
"Observe always that everything is the result of a change, and get used to think- 
ing that there is nothing Nature loves so well .... " wrote Marcus Aurelius 
Antoninus. As I write my first announcement as Publisher, I think Nature must 
be reveling in all the changes that have come to Current Therapeutic Research of 
late. Although many attributes of the journal have changed, one thing remains 
constant--our desire to be an outstanding rapid-publication journal, an objec- 
tive that has been behind many of the changes of recent years. 
For me, the changes in the journal have a personal aspect. It has been near- 
ly 10 years since I began my association with Current Therapeutic Research as 
Reprint Manager, in which position I got to know many authors. Then, as Senior 
Peer Review Manager, where my scientific training came into play, not only did 
I get to know authors but I had the chance to work with our Editor-in-Chief. My 
most recent move results from the retirement of our previous Publisher, Keyo 
Ross. Although Keyo and I had worked closely for many years and I knew that 
retirement was in her plans, the change seems to have come upon us in a flash. 
Also retired is former Editor-in-Chief Dr. Michael Weintraub, who has over- 
seen the scientific content of the journal since 1999. We are fortunate that 
Dr. Weintraub has agreed to accept he title of Editor Emeritus and will contin- 
ue to be a resource to us. Change can be difficult, but it can also be a force for 
advancement. We welcome Dr. Judd L. Walson as our new Editor-in-Chief and 
expect hat he, with his interest in medicine in developing countries, will make 
his unique mark on the journal. 
Finally, one last change: starting with this issue, Current Therapeutic Research 
has a new look. We hope you like it as much as we do. The design continues to 
feature the entire table of contents on the front cover. In addition, we have 
added the Elsevier logo to the cover to highlight he journal's association with 
our parent company. This association has given the journal tremendous reach, 
as Current Therapeutic Research is now available to >6 million subscribers to 
Science Direct worldwide. 
Despite all the innovations, the essence of Current Therapeutic Research 
remains unchanged. The standard for scientific content set by our Editor-in- 
Chief will be maintained and supported by the journal's editorial board. Our 
staff will maintain its editorial excellence and give the same personal attention 
to each manuscript. And like the Publishers before me, I will remain open to 
readers' suggestions, comments, and ideas, for they are the impetus to further 
growth and improvement in the journal. 
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